Effect of Remifentanil on Propofol use administered by PCSA for procedures of diagnosis and surgery by endoscopy. - ND
- Conditions
- patient to underwent operation for surgery or diagnosis endoscopy of the upper gastrointestinal tractMedDRA version: 6.1Level: PTClassification code 10014819
- Registration Number
- EUCTR2006-001683-23-IT
- Lead Sponsor
- OSPEDALE S. RAFFAELE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 69
Inclusion Criteria
patients with age over 18 who have to be submitted to operation for surgery or for diagnosis es endoscopy of the upper gastroenteric tract
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
-
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: to verify if Remifentanil and Propofol togheter may guarantee an adequate anlgesic covering and may allow to reduce the quantity of hypnotic drug;Secondary Objective: -;Primary end point(s): -
- Secondary Outcome Measures
Name Time Method